{content}

Study list

Franke

Germany
|
2023-2025
  • Adults
  • General population
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Corticosteroid
  • Methylprednisolone

NOVELLA

Russian Federation
|
2023-2024
  • Adults
  • Elderly
  • Fragile population
  • Immunocompromised host
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Monoclonal antibodies
  • AZD3152

LCHydroxy

United Kingdom
|
2023-2024
  • Adults
  • General population
  • Elderly
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Hydroxy gas

Zuiani

United Kingdom United States of America
|
2023-2026
  • Adults
  • General population
  • Monkeypox virus
  • Monkeypox virus infection
  • Pharmacological intervention
  • Vaccination
  • BNT166a

Rösner

Germany
|
2023-2025
  • Adults
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention

ALL-VASCOR

Poland
|
2023
  • Adults
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Allopurinol

MonVIP

France
|
2023
  • Adults
  • Fragile population
  • Immunocompromised host
  • People at high risk of STIs
  • People living with HIV
  • PrEP users
  • Hospital wide
  • Outpatient clinic
  • Infectious diseases unit
  • Monkeypox virus
  • Monkeypox virus infection

Stengel

Germany
|
2023
  • Adults
  • General population
  • Healthcare workers
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

Goedecke

Germany
|
2023-2025
  • Adults
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Immunoadsorption

Bahr

Germany
|
2023
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19